Document:

Offer of Employment Letter to Michael Murphy

 Exhibit 10.13 
 

 
 M/A-COM Technology Solutions Inc. 

100 Chelmsford Street 
 Lowell, MA 01851 
 September 28, 2009 

Michael Murphy 
 Re: Offer of
Employment with M/A-COM Technology Solutions Inc. 
 Dear Mike: 
 On behalf of M/A-COM Technology Solutions Inc., a Delaware corporation (the “Company”), I am pleased to invite you to join the Company as its Vice President of Engineering, reporting to
me. This is an exempt position and you will be working out of our 100 Chelmsford St., Lowell MA Corporate Headquarters. Subject to the terms and conditions set forth in this letter, the effective date of your employment will be mutually agreed to in
writing at a later date. 
 The terms of this offer of employment are as follows: 

1. At-Will Employment. You should be aware that your employment with the Company is for no specified period and constitutes
“at-will” employment. As a result, you are free to terminate your employment at any time, for any reason or for no reason. Similarly, the Company is free to terminate your employment at any time, for any reason or for no reason. We request
that, in the event of a resignation, you give the Company at least two weeks’ notice. 
 2. Compensation. The
Company will pay you a salary at the rate of $25,000 per month payable in accordance with the Company’s standard payroll policies, including compliance with applicable withholding. The first and last payment by the Company to you will be
adjusted, if necessary, to reflect a commencement or termination date other than the first or last working day of a pay period. You will also be eligible to participate in a Company bonus plan, with a “target” bonus participation potential
of 50% of your annualized salary per year and a maximum bonus participation potential of up to 80% of your annualized salary per year, based on Company and/or individual performance targets determined by the Board of Directors from time to time. In
addition, as a further incentive to join the Company, the Company is pleased to offer you a one-time retention incentive payment in the amount of $150,000, subject to applicable withholding and payable concurrently with your first regular paycheck
following your 

 
start date with the Company in accordance with the Company’s standard payroll policies (the “Retention Bonus”). The Retention Bonus is being paid to you with the expectation
and requirement that you will be a long-term contributor to the Company’s success. Accordingly, it is being paid to you subject to a “claw-back” forfeiture restriction, which will lapse as to twenty-five percent (25%) of the full
Retention Bonus amount on each successive anniversary of the date the Retention Bonus is paid to you, so long as you provide continuous service as an employee of the Company through each such date. To the extent that your employment with the Company
terminates for any reason other than your death or an Involuntary Termination (as defined in Section 4 below, and provided that you deliver and do not revoke the Release as described in Section 4 below), you agree to reimburse the Company
for the full amount of the Retention Bonus as to which such forfeiture restriction has not yet lapsed as of the date of such termination, within fifteen (15) days following the date your employment terminates, and further agree that the Company
in its sole discretion may (but shall not be required to) elect to reduce the amount of any payment otherwise owed to you pursuant to this letter agreement (including, without limitation, salary, severance, bonus or other amounts) on a dollar for
dollar basis to offset in whole or in part the amount you are required to repay under this Section 2. 
 3. Stock
Options. As you may be aware, the Company’s parent, M/A-COM Technology Solutions Holdings, Inc. (“Parent”), is in the process of setting up a stock option plan to provide certain employees and other service providers with
employment incentives. Subject to the adoption of such plan and approval by the Parent’s Board of Directors in accordance with applicable law, you will be granted: 

(a) An option under the plan (the “First Option”) to purchase six hundred thousand
(600,000) shares of Parent’s Common Stock. One-fifth (1/5th) of the shares subject to the option will vest and become exercisable on the first anniversary of the option vesting commencement date (which will be the date you start work
with the Company) and an additional one sixtieth
(1/60th) of the total number of such shares will vest
on the corresponding day of each month thereafter, or to the extent such a month does not have the corresponding day, on the last day of any such month, until all the shares are vested, subject to your continued employment with the Company at each
such date. 
 (b) An additional option under the plan to purchase two hundred thousand (200,000) shares of
Parent’s Common Stock (the “Second Option”). All of the shares subject to the Second Option shall vest and become exercisable if and only if either (i) the consolidated annual revenue of Parent and all Parent’s
subsidiaries (“Group Revenue”) (less any such revenue attributable to any products, technologies, assets or organizations acquired by Parent or its subsidiaries after the date hereof, other than revenue attributable to any Included
Acquisitions and Exempted Acquisitions as defined below) meets or exceeds $370,000,000 for any fiscal year of Parent ending after the date hereof and on or before December 31, 2012 (the “Revenue Threshold”), or (ii) the
consolidated annual earnings before income tax of Parent and all Parent’s subsidiaries, calculated to exclude any (x) gains or losses from the sale, exchange, transfer or other disposition of property or assets not in the ordinary course
of business of Parent and such subsidiaries, and (y) other extraordinary gains or losses of Parent and such subsidiaries exceeds the greater of (A) $70,000,000 and (B) twenty-five percent (25%) of Group Revenue for any fiscal
year of Parent ending after the date hereof and on or before December 31, 2012. As used in this paragraph, “Included Acquisitions” shall mean products of Parent and its subsidiaries

 
developed as “works made for hire” for Parent or such subsidiaries by one or more unaffiliated third parties hired by Parent or such subsidiaries for such purpose. “Exempted
Acquisitions” as used herein means the next $25,000,000 of revenue attributable to acquisitions of products, technologies, assets or organizations made by Parent or its subsidiaries following the date of this letter agreement, as measured
by the trailing twelve month revenues associated with each such acquired business or group of assets at the time each was acquired. In the event that the trailing twelve month revenue for any Exempted Acquisition, when aggregated with the trailing
twelve month revenue for any prior Exempted Acquisitions, would exceed the $25,000,000 limit noted above, then the amount of post-acquisition revenue attributable to that Exempted Acquisition that may be counted toward achievement of the Revenue
Threshold in any period in accordance with this paragraph shall be limited to the percentage of such post-acquisition revenue attributable to such Exempted Acquisition that (A) the portion of the trailing twelve month revenue for such Exempted
Acquisition which (considered together with the trailing twelve month revenue for any prior Exempted Acquisitions) is not in excess of the $25,000,000 limit represents of (B) the total trailing twelve month revenue for such Exempted
Acquisition. For the avoidance of doubt, the trailing twelve-month revenue of any prior Exempted Acquisitions shall not be included in the numerator of the above-described fraction, but rather used as a reference point for determining such
numerator. 
 (c) The First Option and Second Option will each have a per share exercise price equal to the fair
market value of a share of Parent Common Stock on the date the option is granted, as determined by the Parent Board of Directors. Each option grant shall be subject to the terms and conditions of the Parent stock option plan and related stock option
agreement. No right to any stock is earned or accrued under any such option until such time as vesting occurs, nor does the grant confer any right to continued vesting or employment. 

4. Severance. 
 (a) Our at-will relationship notwithstanding, if the Company terminates your employment with the Company other than for “Cause” (as defined below) or you resign for “Good Reason” (as
defined below) (each an “Involuntary Termination”), and in either case you sign, deliver to the Company and do not revoke a general release of claims in the Company’s favor in a form and substance acceptable to the Company (the
“Release”), then you shall be entitled to receive as severance pay continuation of your monthly salary, as then in effect and payable in accordance with the Company’s standard payroll policies, including compliance with
applicable withholding, for a period of six (6) months following the date your employment with the Company terminated (such period is hereinafter referred to as the “Severance Period”). 

(b) Subject to the same conditions applicable to the receipt of any severance payments otherwise payable during any Severance Period as
set forth in Section 4(a), to the extent that you or any of your dependents may be covered under the terms of any medical and dental plans of the Company immediately prior to the termination of your employment, the Company will provide you with
reimbursement for premiums paid for the continuation of such benefits for you and those dependents for the same or equivalent coverages through the end of the Severance Period. The Company is under no obligation to provide reimbursement for special
coverages for you that 

 
would not be covered by the plans applicable to employees generally. The reimbursement payable to you pursuant to this paragraph shall be reduced by the amount equal to the contributions required
from time to time from other employees for equivalent coverages under the Company’s medical or dental plans. If and to the extent that you or any of your dependents is or becomes eligible to participate in a medical, dental or other health
insurance plan of another employer during the Severance Period, then the reimbursement benefit provided by this paragraph shall be eliminated or commensurately diminished. 
 (c) You hereby agree that the severance benefits provided for in this Section 4 are the only severance benefits to which you may be entitled in the event of the termination of your employment with
the Company, and that such benefits will be reduced dollar for dollar by any severance-related amount the Company is required to pay you by law, corporate policy or other source that would otherwise duplicate any portion of the severance benefits
provided herein. 
 As used herein, “Cause” shall mean (i) an act of dishonesty made by you in connection
with your responsibilities as an employee; (ii) your conviction of, or plea of nolo contendere to, a felony, or commission of an act of moral turpitude; (iii) your gross misconduct; or (iv) your (a) material failure to discharge
your employment duties or (b) a material breach of this offer letter or the ECIA (as defined below), in each case after you have received a written demand for performance from the Company (or notice of misconduct, where applicable) specifying
the breach of employment duties and your failure to cure such breach (where such breach is curable) within thirty (30) days of the date of such notice from the Company. 
 As used herein, “Good Reason” shall mean your resignation within thirty (30) days following the expiration of any Company cure period without the Company providing a cure (discussed
below) following the material reduction by the Company, without your consent, of your authority, duties, or responsibilities with the Company in effect immediately prior to such assignment, or the removal of you from such position and
responsibilities; provided, however, that a reduction in duties, position or responsibilities solely by virtue of the Company being acquired and made part of a larger entity, whether as a subsidiary, business unit or otherwise (as, for example, when
the Chief Financial Officer of the Company remains the Chief Financial Officer of the Company following an acquisition where the Company becomes a wholly owned subsidiary of the acquiror, but is not made the Chief Financial Officer of the acquiring
corporation) will not constitute “Good Reason”. You agree you will not resign for Good Reason without first providing the Company with written notice of the acts constituting the grounds for “Good Reason” within thirty
(30) days of the initial existence of the grounds for “Good Reason” and a reasonable opportunity for the Company to cure such grounds of not less than thirty (30) days following the date of such notice. 

5. Post-Termination Restrictions. 
 (a) Non-Competition. You acknowledge that, as an employee of the Company, you will have access to valuable, proprietary trade secret and other confidential information of the Company in connection
with this letter agreement. You acknowledge that such valuable proprietary and confidential information is developed and acquired by the Company on an ongoing basis and you will receive the benefit of access to new and unique information on a
continuing basis, and that such information is worthy of protection. To further 

 
ensure the confidentiality of the Company’s trade secrets and other proprietary information, during the time you are employed by the Company and also during any Severance Period, you agree
that you shall not directly or indirectly (whether for compensation or otherwise), alone or as a partner, associate, agent, principal, trustee, consultant, co-venturer, creditor, owner (excepting not more than 1% passive stockholdings for investment
purposes in securities of publicly held and traded companies), representative, or in any other capacity, engage in, take any action constituting or in furtherance of, participate with or become interested in or associated with any person, firm,
partnership, corporation or other entity which is or intends to be in competition with the Company in those portions of the Company’s business in which you were involved during your tenure of employment with the Company. You further understand
and agree to be bound by the provisions of this Section 5 because you are employed in a position of trust and responsibility and have access and will have access to current as well as future confidential and proprietary information, and this
covenant is necessary to prevent the inevitable disclosure of confidential and proprietary information should you accept employment in violation of such provisions. 

(b) Non-Solicitation. During the time you are employed by the Company and also during any Severance Period, you
agree that you shall not directly or indirectly (whether for compensation or otherwise), alone or together with others, influence or attempt to influence customers or suppliers of the Company or any of its present or future subsidiaries or
affiliates, either directly or indirectly, to divert their business to any individual, partnership, firm, corporation or other entity then in competition with the business of the Company or any subsidiary or affiliate of the Company. 

(c) Consideration; Tolling, Scope and Reasonableness. You agree that in addition to the other good and valuable
consideration you are receiving for the covenants contained in this Section 5 as recited above, any severance amount payable to you by the Company in respect of any Severance Period hereunder constitutes further consideration for these
covenants. You agree that the periods of time during which you are prohibited by Sections 5(b) and (c) hereof from engaging in such business practices shall be extended by any length of time during which you are in breach of any of such
covenants. The covenants contained in this Section 5 shall apply in any country or jurisdiction where the Company and its affiliates had offices or shipped product during the term of your employment with the Company. You and the Company agree
that the time, scope and geographic limitations and other particulars of the foregoing covenants are appropriate and reasonable when considered in light of the nature and extent of the business conducted by the Company and your role in the Company.

 (d) Remedies. If you commit a breach, or threaten to commit a breach, of any of the provisions of this
Section 5, the Company shall have the following rights and remedies, in addition to any and all others rights and remedies of law or in equity, each of which shall be independent of the other and severally enforceable: (i) the right to
have the provisions of this letter agreement specifically enforced by any court having equity jurisdiction, including the right to a restraining order, an injunction or other equitable relief, it being acknowledged and agreed that any such breach or
threatened breach will cause irreparable injury to the Company and that money damages will not provide an adequate remedy to it; and (ii) the right and remedy to require you to account for and pay over to the Company all compensation, profits,
monies, accruals, increments or other benefits (hereinafter collectively the “Benefits”) derived or 

 
received, directly or indirectly, by you as a result of any transactions constituting a breach of any of the provisions of this letter agreement, and you hereby agree to account for and pay over
any such Benefits to the Company. 
 6. Benefits. During the term of your employment, you will be eligible, provided that
you meet the eligibility requirements of the relevant plans and policies, for the Company’s standard employee benefits applicable to employees at your level, including health, dental, vision, life, short and long-term disability insurance. The
Company reserves the right to change the benefits it offers or the terms of such benefits from time to time. The Company will provide you with an initial combined vacation and PTO day accrual rate equivalent to an employee with thirteen
(13) years of prior service credit. 
 7. Immigration Laws. This offer of employment is contingent on your providing
proper documentation of your identity and authorization to work in the United States under applicable immigration laws, as required by Form I-9 of the US Department of Homeland Security. 

8. Employee Confidentiality and Invention Assignment Agreement. As a condition of this offer of employment, you will be required
to promptly complete, sign and return the Company’s standard form of employee confidentiality and invention assignment agreement (the “ECIA”). 
 9. No Conflicts. In this position, you will be expected to devote your full business time, attention and energies to the performance of your duties with the Company. We also ask that, before
signing this letter, you disclose to the Company any and all agreements relating to your prior employment that may affect your eligibility to be employed by the Company or limit the manner in which you may be employed. It is the Company’s
understanding that any such agreements will not prevent you from performing the duties of your position and you represent that such is the case. 
 10. General. This offer letter and the ECIA, when signed by you, set forth the terms of your employment with the Company and supersede any and all prior representations and agreements made to or
with you by the Company, any of its predecessors or affiliates, or any of their respective employees or agents, whether written or oral. As a Company employee, you will also be expected to abide by Company rules and regulations, whether set forth in
a Company-approved employee handbook or otherwise, that may be modified from time to time. In the event of a conflict between the terms and provisions of this offer letter and the ECIA, the terms and provisions of the ECIA will control. Any
amendment of this offer letter or any waiver of a right under this offer letter must be set forth in a writing signed by you and an authorized officer of the Company to be effective. The law of the state in which you are employed will govern this
offer letter. In the event of any dispute or claim relating to or arising out of our employment relationship, you and the Company agree that we are both waiving any and all rights to a jury trial in connection with such dispute or claim. 

Lastly, this offer of employment is contingent on the satisfactory completion of a background check. It is also contingent in part on
your submitting to a pre-employment drug-screening test for the presence of drugs. Human Resources will provide the necessary documents once you have returned your signed offer letter. 

 We look forward to you joining the Company. If the foregoing terms are agreeable, please
indicate your acceptance by signing this offer letter in the space provided below and returning it to me, along with your completed and signed ECIA. 
  

			
	Sincerely,
	
	M/A-COM Technology Solutions Inc.
		
	By:	 	/s/ Joe Thomas 10/9/09
		 	Joe Thomas
		 	CEO

  

	
	AGREED TO AND ACCEPTED:
	
	/s/ M. Murphy 9/28/09
	Signature of Employee

 Enclosures: 

    ECIA 

 AMENDMENT TO OFFER OF EMPLOYMENT 

This AMENDMENT (“Amendment”) to that certain Offer Letter of Employment with M/A-COM Technology Solutions Inc.
dated as of October 9, 2009 (the “Original Employment Agreement”) is made as of December 21, 2010, by and between M/A-COM Technology Solutions Inc., a Delaware corporation (the “Company”),
and Michael Murphy (the “Employee”). Capitalized terms used herein without definition shall have the respective meanings provided therefor in the Original Employment Agreement. 

RECITALS 

WHEREAS, the Company and the Employee entered into the Original Employment Agreement; 

WHEREAS, the parties now desire to amend the Original Employment Agreement to reflect certain changes to the terms and conditions
contained therein; 
 NOW, THEREFORE, in consideration of the premises and the mutual covenants herein contained, and
other good and valuable consideration the receipt and sufficiency of which is hereby acknowledged, the Company and the Employee hereby agree as follows: 
 AGREEMENT 
 11. Section 4(a) of the Original Employment Agreement is
hereby amended and restated in its entirety as follows: 
 “Our at-will relationship notwithstanding, if the Company
terminates your employment with the Company for any reason other than for “Cause” (as defined below) or you resign for “Good Reason” (as defined below) (each an “Involuntary Termination”), and in either case you
sign and deliver to the Company within 52 days after such termination of employment and do not revoke within any applicable 7-day revocation period (or other revocation period set forth by the Company ending prior to the 60th day after termination
of employment) a general release of claims in the Company’s favor in a form and substance acceptable to the Company (the “Release”), then you shall be entitled to receive as severance pay continuation of your monthly salary, as
in effect and payable in accordance with the Company’s standard payroll policies on the date of such termination (and in no event less frequently than monthly), including compliance with applicable withholding, for a period of six
(6) months following your date of employment with the Company (such period is hereinafter referred to as the “Severance Period”). To the extent required to comply with or be exempt from the requirements
of Section 409A of the Internal Revenue Code of 1986, as amended (“Code Section 409A”), any payments that would otherwise have been made during the 60-day period following your termination of employment shall not
be made and shall be accumulated and paid in a single lump sum after such Release is signed and delivered to the Company and after the expiration of any applicable revocation period (as set forth in the preceding sentence) on or prior to the 60th
day following your termination of employment; provided that if the period of 60 days following your termination of employment spans two calendar years, such accumulated payment to the extent required by Code Section 409A shall be paid in the
second such calendar year.” 

 12. A new Section 4(c) is hereby inserted into the Original Employment Agreement and
the prior Section 4(c) is renumbered as Section 4(d) and all references amended as necessary. The new Section 4(c) is as follows: 
 “Optional Severance. If your employment terminates for any reason other than an Involuntary Termination the Company may elect, in its sole discretion, to pay you severance pay and benefit
reimbursements in the amounts and on the terms set forth in Sections 4(a) and (b) for any period up to six (6) months following the date of termination. If the Company makes such an election, the duration elected by the Company shall be
deemed to be the “Severance Period” for all purposes under this Agreement.” 
 13. Section 5(c) of the
Original Employment Agreement is hereby amended by replacing the phrase “prohibited by Sections 5(b) and (c)” in the second sentence with the phrase “prohibited by Sections 5(a) and (b)”. 

14. A new Section 11 is hereby added to the Original Employment Agreement as follows: 

“This offer of employment is intended to be interpreted and operated to the fullest extent possible so that the payments and benefits
under this offer of employment either shall be exempt from the requirements of Code Section 409A under Treasury Regulation section 1.409A-1(b)(9)(iii) or otherwise or shall comply with the requirements of Code Section 409A; provided,
however, that notwithstanding anything to the contrary in this offer of employment in no event shall the Company be liable to you for or with respect to any taxes, penalties or interest which may be imposed upon you pursuant to Code
Section 409A. In accordance with the preceding sentence, the date on which a “separation from service” pursuant to Code Section 409A occurs shall be treated as the termination of employment date for purposes of determining the
timing of payments and benefits under this offer of employment to the extent necessary to have such payments and benefits under this offer of employment be exempt from the requirements of Code Section 409A or comply with the requirements of
Code Section 409A.” 
 15. Except as expressly amended hereby, the Original Employment Agreement shall remain in full
force and effect. This Amendment shall not, except as expressly provided herein, be deemed to be a consent to any waiver or modification of any other terms or provisions of the Original Employment Agreement. 

16. This Amendment may be signed in any number of counterparts, each of which shall be deemed an original, with the same effect as if the
signatures thereto and hereto were upon the same instrument. 
 [Remainder of page intentionally left blank.] 

 IN WITNESS WHEREOF, the parties have executed this Amendment as of the date first above
written. 
  

			
	M/A-COM TECHNOLOGY SOLUTIONS INC.
		
	By:	 	/s/ Conrad R. Gagnon
	Name:	 	Conrad R. Gagnon
	Its:	 	CFO

  

	
	MICHAEL MURPHY
	
	/s/ Michael MurphyManagement Services Agreement with GaAs Labs, LLC

 Exhibit 10.14 
 [GAAS LABS, LLC LOGO] 
 October 15, 2008 

Mimix Holdings, Inc. 
 10795 Rockley Road

 Houston, TX 77099 
 Ladies and
Gentlemen: 
 As you are aware, following its recent investment in the Series A Preferred Stock of Mimix Holdings, Inc., a
Delaware corporation (“Company”), Gaas Labs, LLC, a California limited liability corporation (“Gaas Labs”) beneficially owns in excess of fifty percent of the outstanding shares of capital stock of the Company and has the right
to appoint a majority of the members of the Company’s board of directors. As you are also aware, since the date of its investment, Gaas Labs has been actively engaged in the provision of financial and strategic consulting, advisory and other
services to the Company (the “Services”) with the aim of furthering the Company’s growth and success. 
 In consideration of the Services rendered to date and to be rendered in connection with the ongoing operations of the Company in the future, the Company agrees to pay Gaas Labs a monthly amount of
compensation equal to the Fee Amount (as defined below), which shall be billed to the Company by Gaas Labs, and shall be due and payable monthly on or before the fifth (5th) day of each calendar month until the earlier of (i) such time as the Gaas Labs and/or its affiliates no
longer hold an equity investment in the Company or representation on the Company’s board of directors (after which time Gaas Labs will cease to provide the Services) and (ii) such time as Gaas Labs and the Company agree in writing to
modify or terminate the arrangements contemplated hereby. 
 The “Fee Amount” shall be equal to the greater of
(i) $60,000, and (ii) ten percent (10%) of the monthly consolidated operating income of the Company, calculated based on the unaudited consolidated monthly financial statements prepared by the Company internally in accordance with
generally accepted accounting principles for each corresponding month of its fiscal year, which financial statements the Company hereby agrees to prepare and deliver to Gaas Labs in accordance with this agreement no later than fifteen
(15) calendar days following the last day of the calendar month to which such financial statements relate. In addition, the Company will reimburse Gaas Labs for its expenses incurred in connection with the provision of the Services. Payments
made by the Company pursuant to this agreement shall be made by wire transfer of immediately available funds to such account as Gaas Labs shall designate to the Company in writing from time to time. 

Gaas Labs may assign its rights and obligations hereunder to any of its affiliates, and shall provide written notice to the Company of
any such assignment. 
 The Company and Gaas Labs hereby agree to the provisions with respect to the Company’s indemnity of
Gaas Labs and other matters set forth in Schedule I attached to this letter agreement, the terms of which are incorporated herein in their entirety. Schedule I is an integral part of this letter agreement and shall survive any termination,
assignment or expiration of this letter agreement. 

 This agreement (and any claim or dispute of any kind or nature whatsoever arising out of, or
relating to, this letter agreement or Gaas Labs’ engagement hereunder, directly or indirectly, including any claim concerning advice provided pursuant to this letter agreement) shall be governed by and construed and enforced in accordance with
the laws of the State of California applicable to contracts made and to be performed entirely within that state. Any rights to trial by jury with respect to any claim, action or proceeding, directly or indirectly, arising out of, or relating to,
this letter agreement or Gaas Labs’ engagement hereunder are hereby waived by Gaas Labs and the Company. 
 In case any
provision of this letter agreement shall be invalid, illegal or unenforceable, the validity, legality and enforceability of the remaining provisions of this letter agreement shall not in any way be affected or impaired thereby. 

Please confirm that the foregoing is in accordance with your understandings and agreements with Gaas Labs by signing a copy of this
agreement in the space provided below. This letter may be signed in one or more counterparts, which together shall form a binding original, and facsimile signatures shall be deemed binding originals hereunder. 

 

			
	Very truly yours,
	
	GAAS LABS, LLC
		
	By:	 	/s/ John Ocampo
	Name:	 	John Ocampo
	Title:	 	President

 ACCEPTED AND AGREED AS OF 
 THE DATE FIRST ABOVE WRITTEN: 
  

			
	MIMIX HOLDINGS, INC.
		
	By:	 	/s/ Rick Montgomery
	Name:	 	Rick Montgomery
	Title:	 	President and Chief Executive Officer

 SCHEDULE I 
 INDEMNIFICATION AGREEMENT 
 The Company agrees to indemnify Gaas Labs, any controlling
person of Gaas Labs and each of their respective directors, officers, employees, consultants, agents, affiliates and representatives (each, an “Indemnified Party”) and hold each of them harmless against any and all losses,
claims, damages, penalties, expenses, liabilities, whether joint or several (collectively, “Liabilities”) to which the Indemnified Parties may become liable, directly or indirectly, arising out of, or relating to, the letter
agreement to which this Schedule I is attached (the “Letter Agreement”) or Gaas Labs’ or any Indemnified Party’s services thereunder, unless it is finally judicially determined without possibility of appeal that the
Liabilities resulted from the gross negligence of Gaas Labs. The Company further agrees to reimburse each Indemnified Party promptly upon request for all expenses (including attorneys’ fees and expenses) as they are incurred by such
Indemnified Party in connection with the investigation of, preparation for, defense of, or providing evidence in, any action, claim, suit, proceeding, inquiry or investigation (each and collectively, an “Action”), directly or indirectly,
arising out of, or relating to, the Letter Agreement or Gaas Labs’ or any Indemnified Party’s services thereunder, whether or not pending or threatened and whether or not any Indemnified Party is a party to such Action. The Company
also agrees that no Indemnified Party shall have any Liability (whether direct or indirect, in contract or tort or otherwise) to the Company or any person asserting claims on behalf of or in right of the Company, directly or indirectly, arising out
of, or relating to, the Letter Agreement or Gaas Labs’ or any Indemnified Party’s services thereunder, unless it is finally judicially determined that such Liability resulted from the gross negligence of Gaas Labs. 

The Company agrees that, without Gaas Labs’ prior written consent, it will not agree to any settlement of, compromise or consent to the
entry of any judgment in or other termination of (each and collectively, a “Settlement”) any Action in respect of which indemnification could be sought hereunder (whether or not Gaas Labs or any other Indemnified Party is an actual or
potential party to such Action), unless (a) such Settlement includes an unconditional release of each Indemnified Party from any Liabilities arising out of such Action and (b) the parties agree that the terms of such Settlement shall
remain confidential. 
 The Company and Gaas Labs agree that if any indemnification or reimbursement sought pursuant to the first
paragraph of this Schedule I is for any reason unavailable or insufficient to hold any Indemnified Party harmless (except by reason of the gross negligence of Gaas Labs) then, whether or not Gaas Labs is the person entitled to indemnification or
reimbursement, the Company and Gaas Labs shall contribute to the Liabilities for which such indemnification or reimbursement is held unavailable in such proportion as is appropriate to reflect (a) the relative benefits to the Company on the one
hand and Gaas Labs on the other hand, in connection with the transaction to which such indemnification or reimbursement relates or (b) if the allocation provided by clause (a) above is not available, in such proportion as is appropriate to
reflect not only the relative benefits referred to in such clause (a), but also the relative fault of the parties as well as any other relevant equitable considerations; provided, however, that in no event shall the amount to be contributed by Gaas
Labs exceed the fees actually received by Gaas Labs under the Letter Agreement. The Company agrees that, for the purposes of this paragraph, the relative benefits to the Company and Gaas Labs of the contemplated transaction (whether or not such
transaction is consummated) shall be deemed to be in the same proportion that the aggregate consideration payable, exchangeable or transferable (or contemplated to be payable, exchangeable or transferable) in such transaction bears to the fees paid
or payable to Gaas Labs under the Letter Agreement. 

 The rights of the Indemnified Parties referred to above shall be in addition to any rights that any
Indemnified Party may otherwise have at law, in equity, by contract or otherwise. 

 [GAAS LABS, LLC LOGO] 

December 21, 2010 
 Mimix
Holdings, Inc. 
 10795 Rockley Road 

Houston, TX 77099 
 Subject: Amendment to GaAs
Labs, LLC Services Agreement 
 Ladies and Gentlemen: 
 As you are aware, Mimix Holdings, Inc., a Delaware corporation (the “Company”), and GaAs Labs, LLC, a California limited liability corporation (“GaAs Labs”), entered into a services
agreement dated October 15, 2008 (the “Original Agreement”), following an investment by GaAs Labs in the Company. The Company and GaAs Labs now desire to amend the Original Agreement as follows: 

(i) The definition of “Fee Amount” is hereby deleted in its entirety and replaced with the following: 

“The “Fee Amount” shall mean $60,000”. 
 (ii) The second paragraph of the Original Agreement is hereby amended and restated in its entirety as follows: 
 “In consideration of the Services rendered to date and to be rendered in connection with the ongoing operations of the Company and/or its corporate parent, M/A-COM Technology Solutions Holdings, Inc.
(“Parent”) in the future, the Company agrees to pay GaAs Labs a monthly amount of compensation equal to the Fee Amount (as defined below), which shall be billed to the Company by GaAs Labs, and shall be due and payable monthly on or before
the fifth (5th) day of each calendar month until the
earlier of any of the following (after which time GaAs Labs will cease to provide the Services and no further Fee Amounts shall be due): (i) such time as GaAs Labs and/or its affiliates no longer hold any equity investment in the Company or
Parent or any representation on the Company’s or Parent’s board of directors, (ii) Parent consummates a Public Offering (as defined in Parent’s Second Amended and Restated Certificate of Incorporation in effect on the date of
this Agreement), (iii) consummation of a Change in Ownership (as defined in Parent’s Second Amended and Restated Certificate of Incorporation in effect on the date of this Agreement) of Parent and (iv) such time as GaAs Labs and the
Company agree in writing to modify or terminate the arrangements contemplated hereby.” 
 Except as specifically provided
above, the Original Agreement shall remain in full force and effect and is hereby ratified and confirmed. 
 Please confirm that
the foregoing is in accordance with your understandings and agreements with GaAs Labs by signing a copy of this agreement in the space provided below. This letter may be signed in one or more counterparts, which together shall form a binding
original, and facsimile signatures shall be deemed binding originals hereunder. 

 
			
	Very truly yours,
	
	GAAS LABS, LLC
		
	By:	 	/s/ John Ocampo
	Name:	 	John Ocampo
	Title:	 	President

 ACCEPTED AND AGREED AS OF 
 THE DATE FIRST ABOVE WRITTEN: 
  

			
	MIMIX HOLDINGS, INC.
		
	By:	 	/s/ Clay Simpson
	Name:	 	Clay Simpson
	Title:	 	Vice President

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00192-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00192-of-00352.parquet"}]]